Showing 81-100 of 503 for: Cochrane Systematic Reviews > Neurologic 
- Cannabinoids for the treatment of dementia
Cochrane Systematic Reviews, 5-Feb-2009
Following the discovery of an endogenous cannabinoid system and the identification of specific cannabinoid receptors in the central nervous system, much work has been done to investigate the main effects of these compounds. There is increasing evidence th
- Cannabinoids for Tourette's Syndrome
Cochrane Systematic Reviews, 11-Aug-2009
Gilles de la Tourette Syndrome (GTS) is a developmental neuropsychiatric disorder characterised by the presence of chronic motor and phonic tics. Drugs currently used in the treatment of GTS either lack efficacy or are associated with intolerable side eff
- Carbamazepine for chronic neuropathic pain and fibromyalgia in adults
Cochrane Systematic Reviews, 10-Apr-2014
This is an update of a Cochrane review entitled 'Carbamazepine for acute and chronic pain in adults' published in Issue 1, 2011. Some antiepileptic medicines have a place in the treatment of neuropathic pain (pain due to nerve damage). This updated review
- Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
Cochrane Systematic Reviews, 7-Jul-2015
This is an updated version of the original Cochrane review published in Issue 1, 2003, of the Cochrane Database of Systematic Reviews.
- Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
Cochrane Systematic Reviews, 13-Aug-2015
This is an updated version of the original Cochrane review published in Issue 2, 2002 and its subsequent update in 2010.
- Carbamazepine versus valproate monotherapy for epilepsy
Cochrane Systematic Reviews, 11-Aug-2009
Carbamazepine and valproate are drugs of first choice for epilepsy. Despite the lack of hard evidence from individual randomized controlled trials, there is strong clinical belief that valproate is the drug of choice for generalized epilepsies and carbama
- Care delivery and self management strategies for adults with epilepsy
Cochrane Systematic Reviews, 29-Jan-2016
Researchers have criticised epilepsy care for adults for its lack of impact, stimulating the development of various service models and strategies to respond to perceived inadequacies.
- Care delivery and self management strategies for children with epilepsy
Cochrane Systematic Reviews, 16-Dec-2015
Epilepsy care for children has been criticised for its lack of impact. Various service models and strategies have been developed in response to perceived inadequacies in care provision for children and their families.
- Carnitine for fatigue in multiple sclerosis
Cochrane Systematic Reviews, 17-Apr-2012
Fatigue is reported to occur in up to 92% of patients with multiple sclerosis (MS) and has been described as the most debilitating of all MS symptoms by 28% to 40% of MS patients.
- Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 12-Nov-2008
As Parkinson's disease progresses the control of motor symptoms often requires the addition of other drugs to levodopa. The principle aim of COMT inhibitor therapy is to increase the duration of effect of each levodopa dose and thus reduce the time patien
- Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 12-Nov-2008
As Parkinson's disease progresses the control of the symptoms often requires the addition of other drugs to levodopa. The principle aim of COMT inhibitor therapy is to increase the duration of effect of the levodopa dose and thus reduce the time patients
- Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders
Cochrane Systematic Reviews, 6-Nov-2013
Management of the neurogenic bladder has the primary objectives of maintaining continence, ensuring low bladder pressure (to avoid renal damage) and avoiding or minimising infection. Options include intermittent urethral catheterisation, indwelling urethr
- Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia
Cochrane Systematic Reviews, 13-Apr-2010
Neuroleptic-induced akathisia is a common, distressing early-onset adverse effect of neuroleptic drugs. It has been associated with poor treatment compliance and an increased risk of relapse.
- Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome
Cochrane Systematic Reviews, 26-Feb-2014
This review is an update of a review first published in Issue 2, 2003, which was substantially updated in Issue 7, 2010. The concept that many neuropathic pain syndromes (traditionally this definition would include complex regional pain syndromes (CRPS))
- Chemotherapy for high-grade glioma
Cochrane Systematic Reviews, 27-Mar-2014
Trials on the effect of systemic chemotherapy on survival and recurrence in adults with high-grade glioma have had inconclusive results. We undertook a systematic review and meta-analysis to assess the effects of such treatment on survival and recurrence.
- Chinese herbal medicine for diabetic peripheral neuropathy
Cochrane Systematic Reviews, 4-Oct-2013
Chinese herbal medicine is frequently used for treating diabetic peripheral neuropathy in China. Many controlled trials have been undertaken to investigate its efficacy.
- Cholinergic medication for antipsychotic‐induced tardive dyskinesia
Cochrane Systematic Reviews, 19-Mar-2018
Tardive dyskinesia (TD) remains a troublesome adverse effect of conventional antipsychotic (neuroleptic) medication. It has been proposed that TD could have a component of central cholinergic deficiency. Cholinergic drugs have been used to treat TD.
- Cholinesterase inhibitors for Alzheimer's disease
Cochrane Systematic Reviews, 18-Mar-2016
** This review is awaiting update with a new protocol. The methods used for the review were acceptable when the review was published but do not meet contemporary standards, and the review is also considerably out of date. Therefore, readers should note th
- Cholinesterase inhibitors for delirium
Cochrane Systematic Reviews, 22-Oct-2008
Delirium is now the preferred term to describe acute confusional states. It is experienced by 10 to 30% of all hospital inpatients. Delirium is potentially reversible and is related to several adverse outcomes, including increased hospital length of stay,
- Cholinesterase inhibitors for dementia with Lewy bodies
Cochrane Systematic Reviews, 27-Apr-2008
Dementia with Lewy bodies (DLB) was first described in 1983, and clinical diagnostic criteria were published in the early to mid 1990s. It has been suggested DLB may account for up to 15-25% of cases of dementia among people aged over 65, although autopsy
